Year archive

Sunshine Lake Pharma Co., Ltd. — 2025 filings

All 41 regulatory filings released by Sunshine Lake Pharma Co., Ltd. (6887) in 2025, sourced directly from the official regulator.

41 Filings

2025 Period

2025 filings (41)

Filing	Released	Lang
Next Day Disclosure Return Transaction in Own Shares	2025-12-31	English
INSIDE INFORMATION EQUITY TRANSFERS BETWEEN MEMBERS OF THE GROUP OF CONTROLLING SHAREHOLDERS M&A Activity	2025-12-29	English
ARTICLES OF ASSOCIATION Governance Information	2025-12-16	English
POLL RESULTS OF THE 2025 SECOND EXTRAORDINARY GENERAL MEETING Declaration of Voting Results & Voting Rights Announcements	2025-12-16	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Regulatory Filings	2025-12-02	English
FORM OF PROXY FOR THE 2025 SECOND EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2025-11-28	English
NOTICE OF THE 2025 SECOND EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2025-11-28	English
(1) PROPOSED GRANT OF REPURCHASE MANDATE; (2) PROPOSED EXTENSION OF GENERAL ISSUE MANDATE; (3) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND (4) NOTICE OF THE 2025 SECOND EXTR Proxy Solicitation & Information Statement	2025-11-28	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2025-11-28	English
CHANGE OF COMPOSITION OF THE NOMINATION COMMITTEE; AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION Regulatory Filings	2025-11-28	English
VOLUNTARY ANNOUNCEMENT INTENTION TO CONDUCT SHARE REPURCHASE Transaction in Own Shares	2025-11-25	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Regulatory Filings	2025-11-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Regulatory Filings	2025-10-06	English
Interim Report 2025 Interim / Quarterly Report H1 2025	2025-09-29	English
CLARIFICATION IN RELATION TO THE CIRCULAR, NOTICE AND PROXY FORM FOR, AND POLL RESULTS OF, THE 2025 FIRST EXTRAORDINARY GENERAL MEETING HELD ON 5 SEPTEMBER 2025 Declaration of Voting Results & Voting Rights Announcements	2025-09-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Share Issue/Capital Change	2025-09-04	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025 Interim / Quarterly Report H2 2025	2025-08-29	English
INSIDE INFORMATION PROPOSED IMPLEMENTATION OF H SHARE FULL CIRCULATION BY THE COMPANY Share Issue/Capital Change	2025-08-29	English
FORM OF PROXY FOR THE 2025 FIRST EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2025-08-19	English
NOTICE OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2025-08-19	English
PROPOSED GRANT OF GENERAL ISSUE MANDATE AND NOTICE OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2025-08-19	English
NOTICE OF BOARD MEETING Regulatory Filings	2025-08-19	English
Notification Letter and Reply Form to Non-Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2025-08-18	English
Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2025-08-18	English
JOINT ANNOUNCEMENT UPDATE REGARDING CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE PHARMA CO., LTD. BY WAY OF MERGER BY ABSORPTION OF YICHANG HEC CHANGJI M&A Activity	2025-08-07	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Governance Information	2025-08-06	English
TERMS OF REFERENCE OF THE REMUNERATION AND APPRAISAL COMMITTEE OF THE BOARD OF DIRECTORS Governance Information	2025-08-06	English
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE OF THE BOARD OF DIRECTORS Governance Information	2025-08-06	English
TERMS OF REFERENCE OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS Governance Information	2025-08-06	English
ARTICLES OF ASSOCIATION Governance Information	2025-08-06	English
JOINT ANNOUNCEMENT WITHDRAWAL OF LISTING OF H SHARES AND EXPECTED TIMELINE FOR THE WITHDRAWAL OF LISTING AND THE IMPLEMENTATION OF THE SHARE EXCHANGE Delisting Announcement	2025-08-05	English
JOINT ANNOUNCEMENT IN RESPECT OF THE SPECIAL DIVIDEND Notice of Dividend Amount	2025-07-31	English
JOINT ANNOUNCEMENT RESULTS OF EXERCISE OF RIGHT OF DISSENTING SHAREHOLDERS M&A Activity	2025-07-23	English
JOINT ANNOUNCEMENT (1) POLL RESULTS OF THE EGM AND THE H SHAREHOLDERS' CLASS MEETING HELD ON MONDAY, 21 JULY 2025 RELATING TO THE PROPOSED CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHAR M&A Activity	2025-07-21	English
Documents on Display Regulatory Filings	2025-06-29	English
LISTING BY WAY OF INTRODUCTION ON THE MAIN BOARD OF THE STOCK EXCHANGE OF HONG KONG LIMITED Regulatory Filings	2025-06-29	English
LISTING BY WAY OF INTRODUCTION OF 112,712,832 H SHARES OF RMB1.00 EACH ON THE MAIN BOARD OF THE STOCK EXCHANGE OF HONG KONG LIMITED Share Issue/Capital Change	2025-06-29	English
COMPOSITE DOCUMENT (1) PROPOSED CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE PHARMA CO., LTD. BY WAY OF MERGER BY ABSORPTION OF YICHANG HEC CHANGJIANG Proxy Solicitation & Information Statement	2025-06-29	English
JOINT ANNOUNCEMENT (1) PROPOSED CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE PHARMA CO., LTD. BY WAY OF MERGER BY ABSORPTION OF YICHANG HEC CHANGJIANG M&A Activity	2025-06-29	English
Application Proof (1st submission) Regulatory Filings	2025-06-11	English
Application Proof (1st submission) Regulatory Filings	2025-06-11	English